NASDAQ:TEM 8 October 2025 - 25 February 2026

Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky. Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle with breast canceren.wikipedia.org. The company’s core focus is on applying AI and data analytics to personalized medicine. Tempus has built what it calls an “operating system” for healthcare: a platform that ingests vast amounts of clinical and molecular data and makes it accessible for treatment decisions and researchinsidermonkey.com. Its goal is to enable doctors and scientists to leverage big data and AI algorithms to tailor treatments to individual patients – improving outcomes in cancer and other diseases. In practice, Tempus provides both diagnostic tests and analytics services. For example, it offers genomic sequencing for tumor profiling, AI-driven diagnostic algorithms, and a suite of data tools that physicians can use to guide therapy selection. The company’s mission statement emphasizes “bringing the power of data and AI to healthcare”, aiming to glean insights from real-world patient data at scaleinsidermonkey.com. Over the past 10 years, Tempus has amassed one of the world’s largest libraries of de-identified clinical and genomic data, covering millions of patients. This data fuels its machine